CVE:BRM BioRem (BRM) Stock Price, News & Analysis C$2.52 +0.08 (+3.28%) (As of 11:21 AM ET) Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsHeadlines About BioRem Stock (CVE:BRM) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get BioRem alerts:Sign Up Key Stats Today's RangeC$2.52▼C$2.5450-Day RangeC$2.21▼C$2.6252-Week RangeC$0.85▼C$2.64Volume11,024 shsAverage Volume26,395 shsMarket CapitalizationC$39.56 millionP/E Ratio12.00Dividend Yield6.47%Price TargetN/AConsensus RatingN/A Company OverviewBioRem Inc., a clean technology engineering company, designs, manufactures, distributes, and sells air pollution control systems that are used to eliminate odors, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs). It offers biofilters for the removal of odors, H2S, VOCs, and HAPs; and biotrickling filters for applications of high levels of H2S or other water-soluble VOCs. The company also provides multi-stage systems to remove odors from various municipal/urban wastewater treatment processes; biogas desulfurization systems; dry scrubber adsorption systems; and cannabis odor control systems. In addition, it offers biological processes and testing services; media sampling and analysis; system review and inspections; and media replacements and spare parts. The company operates in Canada, the United States, China, and internationally. BioRem Inc. was founded in 1990 and is headquartered in Puslinch, Canada.Read More… The centerpiece of Trump’s crypto’s masterplan … (Ad)Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin conference in Nashville … Where he told an adoring crowd that the U.S. would become … “The crypto capital of the planet and the Bitcoin superpower of the world.”Click here to find out more about what could be Trump and JD Vance’s favorite coin. Receive BRM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BioRem and its competitors with MarketBeat's FREE daily newsletter. Email Address BRM Stock News HeadlinesBioRem Second Quarter 2024 Earnings: EPS: CA$0.021 (vs CA$0.006 loss in 2Q 2023)August 29, 2024 | finance.yahoo.comBiorem Reports Second Quarter Results with 77% Increase in Year over Year Revenue and Record Order BacklogAugust 26, 2024 | finance.yahoo.comThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly repeat itself with the AI frenzy. I urge you to watch it before you invest another cent. Again, to be clear, I’m no Chicken Little. Far from it. November 4, 2024 | Porter & Company (Ad)HASH:CA Stock PriceAugust 9, 2024 | seekingalpha.comBiorem Inc.: BIOREM Reports Strong First Quarter Financial Results and Continued Growth in Order BacklogMay 29, 2024 | finanznachrichten.deBIOREM Reports Strong First Quarter Financial Results and Continued Growth in Order BacklogMay 28, 2024 | finance.yahoo.comClosing Bell: Biorem Inc down on Friday (BRM)May 17, 2024 | theglobeandmail.comBiorem Inc BIRMFMay 6, 2024 | morningstar.comSee More Headlines BRM Stock Analysis - Frequently Asked Questions How have BRM shares performed this year? BioRem's stock was trading at C$1.00 at the beginning of the year. Since then, BRM shares have increased by 152.0% and is now trading at C$2.52. View the best growth stocks for 2024 here. How were BioRem's earnings last quarter? BioRem Inc. (CVE:BRM) released its quarterly earnings data on Monday, August, 26th. The company reported $0.02 earnings per share (EPS) for the quarter. The business earned $7.30 million during the quarter. BioRem had a trailing twelve-month return on equity of 59.68% and a net margin of 11.35%. How do I buy shares of BioRem? Shares of BRM stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. What other stocks do shareholders of BioRem own? Based on aggregate information from My MarketBeat watchlists, some other companies that BioRem investors own include TVA Group (TVA.B), Questor Technology (QST), AutoZone (AZO), Cadence Design Systems (CDNS), FormFactor (FORM), Intel (INTC) and K92 Mining Inc. (KNT.V) (KNT). Company Calendar Last Earnings8/26/2024Today11/04/2024Next Earnings (Estimated)12/04/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeCVE SectorIndustrials Industry Pollution & Treatment Controls Sub-IndustryPharmaceutical Products Current SymbolCVE:BRM CUSIPN/A CIKN/A Webwww.biorem.biz Phone+1-519-7679100FaxN/AEmployees34,300Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)C$0.21 Trailing P/E Ratio12.00 Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$3.51 million Net Margins11.35% Pretax MarginN/A Return on Equity59.68% Return on Assets14.61% Debt Debt-to-Equity Ratio48.97 Current Ratio1.57 Quick Ratio1.08 Sales & Book Value Annual SalesC$30.93 million Price / Sales1.28 Cash FlowC$0.68 per share Price / Cash Flow3.70 Book ValueC$0.50 per share Price / Book5.04Miscellaneous Outstanding Shares15,700,000Free FloatN/AMarket CapC$39.56 million OptionableNot Optionable Beta0.85 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report This page (CVE:BRM) was last updated on 11/4/2024 by MarketBeat.com Staff From Our PartnersCRUSHED: How Biden's Replacement Will Devastate Your 401(k)!Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a ...Golden Crest | Sponsored[Charles Payne Live Event] Click to Confirm Your RSVPThe Blueprint to Protect Your Portfolio Charles Payne reveals a strategy few investors know about Unstoppable Prosperity | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredA new way to play the AI boom (act before November 19)There's a new way to play the $15 trillion AI boom. And it's so simple - you can do it right now with as li...Behind the Markets | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioRem Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioRem With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.